A groundbreaking study led by immunologist Sara Trabanelli at the University of Lausanne reveals that the body’s immune system can react not only to actual pathogens but also to the perception of potential threats, such as seeing virtual avatars depicting sickness. The researchers observed that innate lymphoid cells (ILCs), which typically increase in number during real infections, also spiked when participants viewed these virtual sick individuals, particularly when the avatars appeared distant and thus posed a looming threat.
It might seem intuitive that a sick person standing very close would trigger a stronger immune response, but the study’s findings indicate the opposite: sick avatars at a greater distance elicited a stronger immune activation. This counterintuitive outcome can be explained by the brain’s threat-detection and anticipatory mechanisms. When a potential threat is perceived as approaching from afar, the brain may initiate a proactive, heightened immune response to prepare the body well in advance, essentially “priming” defenses before the threat becomes imminent. In contrast, when the sick person is very near, the brain may perceive the threat as immediate and overwhelming, potentially triggering other behavioral responses like avoidance or escape rather than ramping up immune activity.
The link between seeing distant sick people and taking a sugar pill, in terms of the placebo effect, lies in the brain’s ability to translate perception and expectation into real physiological changes. In the study, machine learning analysis revealed that viewing virtual sick avatars activated brain regions involved in threat detection—such as the hypothalamus—that also regulate immune responses, similar to the brain activity observed after flu vaccination. This suggests that the brain does not require actual infection to mobilize the immune system; rather, the perception or anticipation of threat alone can trigger immune activation.
This mechanism mirrors how the placebo effect operates. When someone takes a sugar pill believing it to be medicine, their brain generates expectations of healing, which engage multiple neural circuits responsible for pain relief, emotional regulation, and immune modulation. These expectations initiate biochemical and neurological processes that produce real health benefits, despite the absence of an active drug.
However, scientists have not fully decoded the placebo effect. The new study highlights an important pathway—how anticipation of a threat activates immune defenses—but placebo responses also involve a complex interplay of diverse brain networks, psychological factors like conditioning and belief, and biological systems that differ across individuals and health conditions. Thus, while perceiving distant sickness and taking a placebo share the common element of brain-driven expectation influencing the body, the placebo effect itself remains a multifaceted and not yet completely understood phenomenon.
This new insight does dovetail with decades of research on the placebo effect, a phenomenon where the expectation of healing or harm triggers real physiological changes. The placebo response is broad and multifaceted, encompassing reductions in pain, modulation of emotional states, changes in hormone levels, and immune system adjustments. Mechanistically, placebo effects arise from complex brain networks involving areas such as the prefrontal cortex, anterior cingulate cortex, amygdala, and brainstem regions. These networks engage endogenous opioid and dopamine systems, reduce anxiety, and modulate attention, all of which contribute to symptom relief or immune changes. Conditioning and learning reinforce these effects; for instance, previous experience with a real drug can heighten placebo responsiveness through associative memory.
While the new findings highlight immune cell activation by perceived threats as a key piece, the placebo effect involves not just immune priming but also pain inhibition via opioid pathways, emotional regulation through affective appraisal, and cognitive reinterpretation of symptoms. Therefore, although this study sheds important light on how the brain communicates perceived threat to the immune system—a mechanism likely fundamental to many placebo responses—it represents one critical part of a larger, dynamic system. Fully unraveling the placebo effect requires integrating these diverse neural circuits, learning mechanisms, and psychological components.
In summary, this research provides compelling evidence that the brain’s perception alone can prepare the body’s defenses, offering a biological basis for some placebo phenomena. It advances our understanding of the mind-body interface, illustrating how belief, expectation, and perception can translate into real immune and neurological changes, ultimately opening new pathways to harness the placebo effect therapeutically.
Read More
[1] https://www.nature.com/articles/npp201081
[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC6725834/
[3] https://www.sciencedirect.com/science/article/pii/S0074774218300461
[4] https://pubmed.ncbi.nlm.nih.gov/17550344/
[5] https://www.health.harvard.edu/newsletter_article/the-power-of-the-placebo-effect
[6] https://www.annualreviews.org/content/journals/10.1146/annurev-clinpsy-021815-093015
[7] https://royalsocietypublishing.org/doi/10.1098/rstb.2010.0414
[8] https://www.thelancet.com/journals/lancet/article/PIIS0140673609617062/abstract